Clinical Trials

Find a Clinical Trial

2 Clinical Trials

Intravesical Photodynamic Therapy (PDT) in BCG Refractory/Intolerant Non-Muscle Invasive Bladder Cancer (NMIBC) Patients

This is a phase II, open-label, single-arm, multi-center Study conducted in Canada, the United States and internationally. Patients with NMIBC CIS with or without resected papillary disease (Ta, T1) that are considered bacillus Calmette-Guerin (BCG)-Unresponsive or who are...

Interventional / Recruiting / NCT03945162

Clinical Trial Details

INSTILADRIN® in Patients With Bacillus Calmette-Guerin (BCG) Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC)

Previous multi-dose Phase I and Phase II clinical studies have demonstrated that INSTILADRIN (nadofaragene firadenovec) is a safe and effective treatment for BCG-refractory and recurrent NMIBC. This Phase III study is designed to expand those observations using a high dose...

Interventional / Active / NCT02773849

Clinical Trial Details

Commonly Searched Clinical Trials

View All Clinical Trials
Breast Cancer
CAR T-Cell Therapy
Crohn's Disease
Diabetes
Leukemia
Neuroblastoma
Neurosciences
Prostate Cancer

Please note that acceptance into any study is dependent on full clinical evaluation as well as details of study status, both of which can only be fully evaluated at the time of a formal visit and screening.